- Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
- Adverum Announces Shortened Timelines and Clear Development Path for ADVM-022 Intravitreal Gene Therapy in Wet AMD, Reports Recent Business Progress and Fourth Quarter 2020 Financial Results
- Starton Therapeutics and Haisco Pharmaceutical Announce an Exclusive Licensing Agreement to Develop and Commercialize STAR-OLZ for Nausea and Vomiting in China
- Onconova Therapeutics to Participate in Three Investment Conferences During the Month of March
- $106.9 Billion Biobanks (Virtual, Physical) Markets, 2028
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University
- Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
- MacroGenics to Participate in Upcoming Investor Conferences
- Recro Reports Fourth Quarter and Year End 2020 Financial Results
